← Back
$COCP All transactions

Cocrystal Pharma, Inc.

A

$ Value

$0

Shares

49,229

Price

$0

Filed

Jan 13

Insider

Name

Martin James Joseph

Title

Co-CEO and CFO

CIK

0001510224

Roles

Officer

Transaction Details

Transaction Date

2026-01-09

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

49,229

Footnotes

The grant of the Issuer's non-qualified stock options was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Compensation Committee of the Board of Directors. The non-qualified stock options are granted under the Issuer's 2025 Equity Incentive Plan and the exercisability shall be subject to execution of the Issuer's form of Non-Qualified Stock Option Agreement. The non-qualified stock options shall vest as follows: one-half shall vest and become exercisable on January 9, 2027 and the remaining half shall vest and become exercisable in eight equal quarterly installments commencing on March 31, 2027, subject to the Reporting Person continuing to serve as an officer of the Issuer on each applicable vesting date.

Filing Info

Accession No.

0001493152-26-002036

Form Type

4

Issuer CIK

0001412486

Martin James Joseph's History

Date Ticker Type Value
2026-01-09 COCP A $0
2025-10-28 COCP A $5K
2025-10-28 COCP A $10K

Other Insiders at COCP (90d)

Insider Bought Sold Last
FROST PHILLIP MD ET AL $47K 2026-02-06